Stephen Orlin, MD
Cornea and External Diseases Specialist · Philadelphia, PANPI 1053341149
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $2,375 of the $2,747 with a category attached, or 86.5%. AbbVie accounts for 86.5% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2019 at $978 and has fallen 97.1% since, to $28 in 2024.
Across 8 payments — averaging $343.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Dompe US, Inc.$357
- Amgen$15
What the payments were for
- Consulting fees$2,37586%
- Food & beverage$37214%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 3 | $2,375 |
| Dompe US, Inc. | 4 | $357 |
| Amgen | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few cornea and external diseases specialist providers in Pennsylvaniato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 997 | $30,451 |
| Cyclosporine | 22 | $15,553 |
| Ketorolac Tromethamine | 661 | $8,051 |
| Loteprednol Etabonate | 28 | $3,605 |
| Brimonidine Tartrate | 30 | $2,742 |
| Difluprednate | 17 | $2,248 |
| MoxifloxacinMoxifloxacin Hcl | 61 | $2,015 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 49 | $857 |
| ValacyclovirValacyclovir Hcl | 30 | $707 |
| Latanoprost | 48 | $459 |
| ErythromycinErythromycin Base | 19 | $257 |
Paid to pharmacies, not to this prescriber.
Other cornea and external diseases specialist in Philadelphia
- Giacomina Massaro-GiordanoPhiladelphia$64K
- Michael SulewskiPhiladelphia$829
- Ashley KhaliliPhiladelphia$96
- Vatinee BunyaPhiladelphia$0
- Brian ShaferPlymouth Meeting$736K
- Stuart CarterAllentown$4K
- Hamza PashaCranberry Township$3K
- Kevin ShahWyomissing$3K
- Mira AminNorth Wales$2K
- Sabrina MukhtarPittsburgh$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.